Nanomedicine News

RSS

Nanostructured Porous Silicon for Chemotherapy Drug Delivery Behaves Differently in Cancerous Tumors

A team of Israeli and American researchers have found that silicon nanomaterials used for the localized delivery of chemotherapy drugs behave differently in cancerous tumors than they do in healthy tissues. The findings could help scientists better design such materials to facilitate the controlled and targeted release of the chemotherapy drugs to tumors.

13 Feb 2015

FDA Grants NanoSmart Orphan Drug Designation for ANA-Conjugated Liposomal Doxorubicin

NanoSmart® Pharmaceuticals, Inc., a private pharmaceutical company developing nanoparticle drug delivery platforms, has received Orphan Drug Designation from the Food and Drug Administration (FDA) for one of its lead candidates, antinuclear antibody (ANA) conjugated liposomal doxorubicin. The drug product is initially intended to treat Ewing's sarcoma, a rare type of cancer that develops in or around children's bones, with potential expansion into other indications.

12 Feb 2015

Heating Targeted Nano-Sized Drug Parcels Improves Delivery to Tumour Cells

Manchester scientists have found that gentle heating of targeted nano-sized drug parcels more effectively in deliver them to tumour cells – resulting in an improvement in survival rates.

12 Feb 2015

New Report on Global Nanobiotechnology Market

Research and Markets has announced the addition of Jain PharmaBiotech's new report "Nanobiotechnology Applications, Markets and Companies" to their offering.

From Research and Markets 12 Feb 2015

BIONOVA Offers Treatment for Blemish Control

Blemish skin is a common problem often confused with Acne. The cause of skin blemishes is the local imbalance of skin metabolism while Acne is a skin decease caused by hormonal imbalances, overactive sebum production (skin oil) and the existence of a specific bacterial flora. If Acne skin is always Oily, Blemish skin can be Normal, Oily and Dry type.

12 Feb 2015

Panacea, Accelovance Enter Agreement to Advance Novel Nanoparticle-Based Therapeutic Cancer Vaccine

Panacea Pharmaceuticals, Inc. and Accelovance Inc. today announced the establishment of a clinical development services agreement to develop and advance Panacea's oncology immunotherapy pipeline.

12 Feb 2015

Scottish Medicines Consortium Recommends ABRAXANE-Gemcitabine Combination for Metastatic Pancreatic Cancer Treatment

Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation, today announced that ABRAXANE®(paclitaxel formulated as albumin-bound nanoparticles; nab-paclitaxel), in combination with gemcitabine, has now received a positive recommendation for the treatment of metastatic pancreatic cancer by the Scottish Medicines Consortium (SMC) within the National Health Service Scotland.

12 Feb 2015

New Report on Global Transdermal Drug Delivery Market

ReportsnReports.com adds Global & USA Transdermal Drug Delivery Market to 2020: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and SWOT Investigation research report to its store.

11 Feb 2015

Novel 3D Vaccine Offers More Effective Method to Harness the Immune System to Fight Cancer

NIBIB-funded researchers have developed a novel 3D vaccine that could provide a more effective way to harness the immune system to fight cancer as well as infectious diseases. The vaccine spontaneously assembles into a scaffold once injected under the skin and is capable of recruiting, housing, and manipulating immune cells to generate a powerful immune response. The vaccine was recently found to be effective in delaying tumor growth in mice.

11 Feb 2015

Vaxxas Secures A$25 Million Equity Funding to Advance Clinical Programs Using Nanopatch Vaccine Platform

Vaxxas, a biotechnology company commercializing a novel vaccination platform, today announced it has secured equity funding of A$25 million [US$20 million] from new and existing investors.

10 Feb 2015

Nanomedicine News

Nanostructured Porous Silicon for Chemotherapy Drug Delivery Behaves Differently in Cancerous Tumors

FDA Grants NanoSmart Orphan Drug Designation for ANA-Conjugated Liposomal Doxorubicin

Heating Targeted Nano-Sized Drug Parcels Improves Delivery to Tumour Cells

New Report on Global Nanobiotechnology Market

BIONOVA Offers Treatment for Blemish Control

Panacea, Accelovance Enter Agreement to Advance Novel Nanoparticle-Based Therapeutic Cancer Vaccine

Scottish Medicines Consortium Recommends ABRAXANE-Gemcitabine Combination for Metastatic Pancreatic Cancer Treatment

New Report on Global Transdermal Drug Delivery Market

Novel 3D Vaccine Offers More Effective Method to Harness the Immune System to Fight Cancer

Vaxxas Secures A$25 Million Equity Funding to Advance Clinical Programs Using Nanopatch Vaccine Platform

Green Synthesis of Silver Nanoparticles Using Pomegranate Peel Extract

Breakthrough Nano Material Uses Sunlight to Tackle Pollution and Produce Energy

Building a Quantum Model with Nanoscale Carbon Molecules

Thermo Fisher Scientific Introduces the Vulcan™ Automated Lab to Transform Semiconductor Analysis

Nanotechnology Could Improve Odds in Treating Aggressive Breast Cancers

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Sponsored Content

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination

Optimizing EV Lubricants with Electrified Tribotesting

Why is 316L Stainless Steel Important for Production?